Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T21:18:46.912Z.
Calculation as of: 2026-10-06T21:18:46.912Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f896dd83f1f74da7f4e84885d6bb04cd833df246353afdbeec9bf8c0bdc7d1c4
PE RATIO
N/A
PE RATIO AVG TTM
4.20
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$262.92M
PE Ratio
N/A
TTM Avg
175.46
3Y Avg
175.46
5Y Avg
175.46
Market Cap
$259.56M
PE Ratio
N/A
TTM Avg
16.07
3Y Avg
13.93
5Y Avg
35.67
Market Cap
$259.12M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc. (XFOR) | $261.27M | N/A | 4.20 | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | N/A | 175.46 | 175.46 | 175.46 |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | N/A | 16.07 | 13.93 | 35.67 |
| Treace Medical Concepts, Inc. (TMCI)vs › | $259.49M | N/A | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | N/A | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | N/A | 4.44 | 4.44 | 4.44 |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | N/A | 15.73 | 15.73 | 15.86 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$2.77
Forward EPS (Est.)
$-0.65
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2025-08-08 | 0.70 |
| 2025-08-07 | 0.69 |
| 2025-08-06 | 0.74 |
| 2025-08-05 | 0.76 |
| 2025-08-04 | 0.74 |
| 2025-08-01 | 0.75 |
| 2025-07-31 | 0.79 |
| 2025-07-30 | 0.83 |
| 2025-07-29 | 0.91 |
| 2025-07-28 | 1.00 |
| 2025-07-25 | 0.85 |
| 2025-07-24 | 0.86 |
| 2025-07-23 | 0.70 |
| 2025-07-22 | 0.70 |
| 2025-07-21 | 0.72 |
| 2025-07-18 | 0.67 |
| 2025-07-17 | 0.70 |
| 2025-07-16 | 0.71 |
| 2025-07-15 | 0.69 |
| 2025-07-14 | 0.69 |
| 2025-07-11 | 0.67 |
| 2025-07-10 | 0.74 |
| 2025-07-09 | 0.78 |
| 2025-07-08 | 0.78 |
| 2025-07-07 | 0.79 |
| 2025-07-03 | 0.89 |
| 2025-07-02 | 0.93 |
| 2025-07-01 | 0.87 |
| 2025-06-30 | 0.89 |
| 2025-06-27 | 0.86 |
| 2025-06-26 | 0.94 |
| 2025-06-25 | 0.99 |
| 2025-06-24 | 1.08 |
| 2025-06-23 | 1.14 |
| 2025-06-20 | 1.25 |
| 2025-06-18 | 1.32 |
| 2025-06-17 | 1.29 |
| 2025-06-16 | 1.28 |
| 2025-06-13 | 1.32 |
| 2025-06-12 | 1.43 |
| 2025-06-11 | 1.51 |
| 2025-06-10 | 1.67 |
| 2025-06-09 | 1.94 |
| 2025-06-06 | 2.02 |
| 2025-06-05 | 1.74 |
| 2025-06-04 | 1.90 |
| 2025-06-03 | 1.86 |
| 2025-06-02 | 1.79 |
| 2025-05-30 | 1.60 |
| 2025-05-29 | 1.65 |
| 2025-05-28 | 1.53 |
| 2025-05-27 | 1.59 |
| 2025-05-23 | 1.46 |
| 2025-05-22 | 1.52 |
| 2025-05-21 | 1.30 |
| 2025-05-20 | 1.27 |
| 2025-05-19 | 1.37 |
| 2025-05-16 | 1.37 |
| 2025-05-15 | 1.42 |
| 2025-05-14 | 1.52 |
| 2025-05-13 | 1.55 |
| 2025-05-12 | 1.57 |
| 2025-05-09 | 1.58 |
| 2025-05-08 | 1.54 |
| 2025-05-07 | 1.52 |
| 2025-05-06 | 1.51 |
| 2025-05-05 | 1.55 |
| 2025-05-02 | 1.75 |
| 2024-11-13 | 3.25 |
| 2024-11-12 | 6.94 |
| 2024-11-11 | 7.77 |
| 2024-11-08 | 7.24 |
| 2024-11-07 | 7.23 |
| 2024-11-06 | 6.79 |
| 2024-11-05 | 6.52 |
| 2024-11-04 | 6.23 |
| 2024-11-01 | 6.08 |
| 2024-10-31 | 5.86 |
| 2024-10-30 | 6.08 |
| 2024-10-29 | 5.83 |
| 2024-10-28 | 5.86 |
| 2024-10-25 | 5.70 |
| 2024-10-24 | 5.68 |
| 2024-10-23 | 5.91 |
| 2024-10-22 | 5.92 |
| 2024-10-21 | 5.81 |
| 2024-10-18 | 6.09 |
| 2024-10-17 | 5.82 |
| 2024-10-16 | 6.25 |
| 2024-10-15 | 6.52 |
| 2024-10-14 | 6.54 |
| 2024-10-11 | 6.00 |
| 2024-10-10 | 6.14 |
| 2024-10-09 | 6.22 |
| 2024-10-08 | 6.34 |
| 2024-10-07 | 6.20 |
| 2024-10-04 | 7.28 |
| 2024-10-03 | 7.38 |
| 2024-10-02 | 7.14 |
| 2024-10-01 | 7.45 |
| 2024-09-30 | 7.84 |
| 2024-09-27 | 7.68 |
| 2024-09-26 | 7.73 |
| 2024-09-25 | 7.54 |
| 2024-09-24 | 8.39 |
| 2024-09-23 | 8.27 |
| 2024-09-20 | 8.29 |
| 2024-09-19 | 8.29 |
| 2024-09-18 | 8.24 |
| 2024-09-17 | 8.23 |
| 2024-09-16 | 7.77 |
| 2024-09-13 | 8.32 |
| 2024-09-12 | 7.95 |
| 2024-09-11 | 8.06 |
| 2024-09-10 | 8.09 |
| 2024-09-09 | 7.79 |
| 2024-09-06 | 7.63 |
| 2024-09-05 | 7.91 |
| 2024-09-04 | 8.02 |
| 2024-09-03 | 7.73 |
| 2024-08-30 | 8.20 |
| 2024-08-29 | 8.12 |
| 2024-08-28 | 8.09 |
| 2024-08-27 | 8.20 |
| 2024-08-26 | 8.55 |
| 2024-08-23 | 8.79 |
| 2024-08-22 | 8.91 |
| 2024-08-21 | 9.08 |
| 2024-08-20 | 8.65 |
| 2024-08-19 | 8.30 |
| 2024-08-16 | 8.14 |
| 2024-08-15 | 7.41 |
| 2024-08-14 | 7.19 |
| 2024-08-13 | 7.09 |
| 2024-08-12 | 7.45 |
| 2024-08-09 | 7.38 |
